Gout News and Research

Latest Gout News and Research

Removing damaged mitochondria may relieve chronic inflammatory conditions

Researchers have discovered a potential new way to treat chronic inflammatory diseases, by eliminating damaged mitochondria before they trigger excessive inflammation.

12 Apr 2019

Researchers discover unique approach to treat some chronic inflammatory diseases

Inflammation is a balanced physiological response -- the body needs it to eliminate invasive organisms and foreign irritants, but excessive inflammation can harm healthy cells, contributing to aging and chronic diseases.

12 Apr 2019

Gout treatment could potentially reduce complications accompanying metabolic syndrome

The drug colchicine, used to treat the arthritic condition gout, could potentially reduce complications accompanying metabolic syndrome, a combination of high blood pressure, high blood sugar and other conditions that increase the risk of heart disease and type 2 diabetes, according to researchers at the National Institutes of Health.

2 Apr 2019

Success for new cholesterol-lowering drug

A new, oral drug that effectively lowers LDL or "bad" cholesterol, looks set for clinical approval.

14 Mar 2019

Researchers review applications, properties, and pharmacological potentials of rose hip

The genus Rosa from family Rosaceae is one of the most widespread species from the family. One species, rose hip, is known as a good source of different types of micronutrients and phytochemicals such as phenolic acids, tannins, and flavonoids. It is known as a traditional treatment in folk medicine.

28 Dec 2018

New study solves longstanding mystery in innate immunity

UT Southwestern biochemist and Breakthrough Prize winner Dr. Zhijian "James" Chen's newest study answers a long-standing question in the field of innate immunity.

29 Nov 2018

Antidepressant use increased after Brexit vote

A new study has shown that use of antidepressants have risen in England after the United Kingdom voted to leave the European Union. There has also been a sharp fall in prescription of other medications, the study notes.

22 Nov 2018

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva® in people with previously untreated chronic lymphocytic leukemia and co-existing medical conditions, met its primary endpoint and showed a statistically significant reduction in the risk of disease worsening or death compared to standard-of-care Gazyva plus chlorambucil.

1 Nov 2018

Study: Nurse-led care can be more successful in managing gout

Providing nurse-led care for people suffering with the painful, long-term condition gout could lead to an increase in the number of patients sticking to a beneficial treatment plan, a clinical trial has revealed.

19 Oct 2018

Genes cause gout not diet

It has been believed for centuries that a diet rich in red meat and wine is associated with gout. This painful joint disease leads to extremely painful swelling of the joints (mainly of the great toes). This is caused due to elevation of uric acid in blood that gets deposited around the joints causing pain and inflammation.

11 Oct 2018

OSA patients have higher risk of developing gout, research reveals

New research reveals that people with obstructive sleep apnea (OSA) have a higher risk of developing gout, even beyond the first years after being diagnosed with the sleep disorder. The findings are published in Arthritis & Rheumatology, an official journal of the American College of Rheumatology.

30 Aug 2018

Foot specialist explains steps to be taken to mitigate foot-related issues

Most Americans will have walked 75,000 miles by the time they reach the age of 50 – the equivalent of trekking around the Earth on the equator three times – an amazing feat.

23 Aug 2018

Scientists map regulatory landscape of mouse genome at single-cell resolution

Scientists have completed a major effort to map the regulatory landscape of the mouse genome at a single-cell resolution.

2 Aug 2018

Newly identified target may lead to discovery of treatments for chronic inflammatory diseases

Inflammation is part of the body's natural healing process. But when it becomes chronic, inflammation can lead to cancer, Alzheimer's disease and other conditions.

26 Jul 2018

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.

20 Jul 2018

A systematic approach towards diagnosis and treatment of rheumatoid arthritis

Rheumatoid Arthritis: A systematic approach (edited by Dr. Syuichi Koarada) comprehensively covers each aspect of the pathology, diagnosis and treatment of rheumatoid arthritis.

26 Jun 2018

Novel cellular pathway may clarify how arterial inflammation develops into atherosclerosis

Investigators have identified a new cellular pathway that may help explain how arterial inflammation develops into atherosclerosis-;deposits of cholesterol, fats and other substances that create plaque, clog arteries and promote heart attacks and stroke. The findings could lead to improved therapies for atherosclerosis, a leading cause of death worldwide.

22 Jun 2018

Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate that canakinumab significantly reduced the rate of gout by more than half compared to placebo, regardless of baseline serum urate level.

18 Jun 2018

Study shows improvements in adherence, outcomes of gout patients receiving text message reminders

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate significant improvements in adherence and clinical outcomes in gout patients who received a daily text message to remind them to take allopurinol.

14 Jun 2018

Virtual follow-up visits for hypertension care just as effective as in-person office visits

Virtual follow-up visits for patients with hypertension appeared to be just as effective as in-person office visits in helping maintain blood pressure control.

24 May 2018

Gout News and Research

Latest Gout News and Research

Removing damaged mitochondria may relieve chronic inflammatory conditions

Researchers discover unique approach to treat some chronic inflammatory diseases

Gout treatment could potentially reduce complications accompanying metabolic syndrome

Success for new cholesterol-lowering drug

Researchers review applications, properties, and pharmacological potentials of rose hip

New study solves longstanding mystery in innate immunity

Antidepressant use increased after Brexit vote

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Study: Nurse-led care can be more successful in managing gout

Genes cause gout not diet

OSA patients have higher risk of developing gout, research reveals

Foot specialist explains steps to be taken to mitigate foot-related issues

Scientists map regulatory landscape of mouse genome at single-cell resolution

Newly identified target may lead to discovery of treatments for chronic inflammatory diseases

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

A systematic approach towards diagnosis and treatment of rheumatoid arthritis

Novel cellular pathway may clarify how arterial inflammation develops into atherosclerosis

Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows

Study shows improvements in adherence, outcomes of gout patients receiving text message reminders

Virtual follow-up visits for hypertension care just as effective as in-person office visits

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Gout News and Research

Latest Gout News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in